Psilocybin (the active ingredient in magic mushrooms), MDMA (ecstasy), and ibogaine are all classified as Schedule I — the most restricted category of drugs under US federal law. Moving a drug out of that category requires a long chain of government steps that takes years, and none of those steps are currently in motion. Nothing will change in the next 30 days.
Administrative rescheduling requires an HHS scientific recommendation, DEA notice of proposed rulemaking, comment period, and final rule — a multi-year pipeline. None of these procedural steps are currently pending in the Federal Register, so no final rule can appear within the next 30 days.